Literature DB >> 1318346

Assembly of IgH CDR3: mechanism, regulation, and influence on antibody diversity.

L VanDyk1, K Meek.   

Abstract

The most variable portion of immunoglobulin molecules is the third complementarity determining region (CDR3) of the heavy chain. This is simply because CDR3 encompasses the region of the rearranged gene where the three gene segments (VH-DH-JH) are joined. Since imprecisions exist in the recombinase reaction, significant differences can be generated at the sites of recombination. This results in the generation of antigen receptor molecules which can differ in their antigen specificity even though they derive from the same germline information. In sum, the significance of the inaccuracy in recombination is that antibodies which are reactive to different antigens can be derived from identical genetic information. This explains how the immune system (using only a limited amount of genetic information) can generate antibodies to virtually any antigen. Though the basic phenomenon of VH-DH-JH assembly has been appreciated for years, two recent findings demonstrate that the generation of CDR3 is more complex than originally believed. First, junctional modification is not a stochastic process as was initially presumed, but is in part developmentally regulated. Second, it has now been well documented that more complex recombinations (for example VH-DH-DH-JH, VH-DH-invDH-JH, etc.) are involved in generating the third hypervariable region of the heavy chain. Not only do these unusual rearrangements--which break the so-called "12/23" recombination rule--occur, but interestingly, certain predicted rearrangements (even some which do follow the "12/23" recombination rule) cannot be demonstrated and apparently do not occur. To date, there is no adequate explanation for the lack of these predicted recombinations. These results have important implications for both the generation of antibody diversity and the recombinase reaction itself.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1318346     DOI: 10.3109/08830189209055568

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  11 in total

1.  Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity.

Authors:  E T Boder; K S Midelfort; K D Wittrup
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

2.  Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.

Authors:  Adrian J Reber; Tatiana Chirkova; Jin Hyang Kim; Weiping Cao; Renata Biber; David K Shay; Suryaprakash Sambhara
Journal:  Aging Dis       Date:  2011-09-30       Impact factor: 6.745

3.  Potential aggregation-prone regions in complementarity-determining regions of antibodies and their contribution towards antigen recognition: a computational analysis.

Authors:  Xiaoling Wang; Satish K Singh; Sandeep Kumar
Journal:  Pharm Res       Date:  2010-04-27       Impact factor: 4.200

Review 4.  Detection of minimal residual disease in multiple myeloma and acute leukaemia.

Authors:  M H Bakkus; N Juge-Morineau; J E van der Werff ten Bosch
Journal:  Med Oncol       Date:  1996-06       Impact factor: 3.064

5.  Analysis of the expressed heavy chain variable-region genes of Macaca fascicularis and isolation of monoclonal antibodies specific for the Ebola virus' soluble glycoprotein.

Authors:  Chris Druar; Surinder S Saini; Meredith A Cossitt; Fei Yu; Xiangguo Qiu; Thomas W Geisbert; Steven Jones; Peter B Jahrling; Donald I H Stewart; Erik J Wiersma
Journal:  Immunogenetics       Date:  2005-11-08       Impact factor: 2.846

6.  Molecular features of the broadly neutralizing immunoglobulin G1 b12 required for recognition of human immunodeficiency virus type 1 gp120.

Authors:  Michael B Zwick; Paul W H I Parren; Erica O Saphire; Sarah Church; Meng Wang; Jamie K Scott; Philip E Dawson; Ian A Wilson; Dennis R Burton
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

7.  Terminal deoxynucleotidyl transferases from elasmobranchs reveal structural conservation within vertebrates.

Authors:  Simona Bartl; Ann L Miracle; Lynn L Rumfelt; Thomas B Kepler; Evonne Mochon; Gary W Litman; Martin F Flajnik
Journal:  Immunogenetics       Date:  2003-10-25       Impact factor: 2.846

Review 8.  The ageing human B cell repertoire: a failure of selection?

Authors:  D K Dunn-Walters
Journal:  Clin Exp Immunol       Date:  2015-10-06       Impact factor: 4.330

9.  Inversions produced during V(D)J rearrangement at IgH, the immunoglobulin heavy-chain locus.

Authors:  A E Sollbach; G E Wu
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

10.  Many Routes to an Antibody Heavy-Chain CDR3: Necessary, Yet Insufficient, for Specific Binding.

Authors:  Sara D'Angelo; Fortunato Ferrara; Leslie Naranjo; M Frank Erasmus; Peter Hraber; Andrew R M Bradbury
Journal:  Front Immunol       Date:  2018-03-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.